Literature DB >> 3362670

High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus.

H G Stunnenberg1, H Lange, L Philipson, R T van Miltenburg, P C van der Vliet.   

Abstract

Initiation of Adenovirus (Ad) DNA replication occurs by a protein-priming mechanism in which the viral precursor terminal protein (pTP) and DNA polymerase (pol) as well as two nuclear DNA-binding proteins from uninfected HeLa cells are required. Biochemical studies on the pTP and DNA polymerase proteins separately have been hampered due to their low abundance and their presence as a pTP-pol complex in Ad infected cells. We have constructed a genomic sequence containing the large open reading frame from the Ad5 pol gene to which 9 basepairs from a putative exon were ligated. When inserted behind a modified late promoter of vaccinia virus the resulting recombinant virus produced enzymatically active 140 kDa Ad DNA polymerase. The same strategy was applied to express the 80 kDa pTP gene in a functional form. Both proteins were overexpressed at least 30-fold compared to extracts from Adenovirus infected cells and, when combined, were fully active for initiation in an in vitro Adenovirus DNA replication system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3362670      PMCID: PMC336381          DOI: 10.1093/nar/16.6.2431

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  Cellular transformation by adenovirus type 5 is influenced by the viral DNA polymerase.

Authors:  B W Miller; J Williams
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Expression of enzymatically active adenovirus DNA polymerase from cloned DNA requires sequences upstream of the main open reading frame.

Authors:  L M Shu; M S Horwitz; J A Engler
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

3.  Multiple rounds of adenovirus DNA synthesis in vitro.

Authors:  M S Horwitz; H Ariga
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

4.  Differential effect of aphidicolin on adenovirus DNA synthesis and cellular DNA synthesis.

Authors:  M M Kwant; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1980-09-11       Impact factor: 16.971

5.  Adenovirus DNA replication in vitro: characterization of a protein covalently linked to nascent DNA strands.

Authors:  M D Challberg; S V Desiderio; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Immunological analysis of 140-kDa adenovirus-encoded DNA polymerase in adenovirus type 2-infected HeLa cells using antibodies raised against the protein expressed in Escherichia coli.

Authors:  Y Sasaguri; T Sanford; P Aguirre; R Padmanabhan
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

7.  Identification of the gene and mRNA for the adenovirus terminal protein precursor.

Authors:  B W Stillman; J B Lewis; L T Chow; M B Mathews; J E Smart
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

8.  The effect of aphidicolin on adenovirus DNA synthesis.

Authors:  M Longiaru; J E Ikeda; Z Jarkovsky; S B Horwitz; M S Horwitz
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

9.  Incorporation of 5-bromodeoxycytidine in the adenovirus 2 replication origin interferes with nuclear factor 1 binding.

Authors:  E de Vries; S M Bloemers; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

10.  Related functional domains in virus DNA polymerases.

Authors:  B A Larder; S D Kemp; G Darby
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

View more
  38 in total

1.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.

Authors:  Y M Mul; C P Verrijzer; P C van der Vliet
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator.

Authors:  P Lemaire; C Vesque; J Schmitt; H Stunnenberg; R Frank; P Charnay
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

Review 3.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

4.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

5.  Expression of adenovirus type 2 DNA polymerase in insect cells infected with a recombinant baculovirus.

Authors:  C J Watson; R T Hay
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

6.  Selective modification of adenovirus replication can be achieved through rational mutagenesis of the adenovirus type 5 DNA polymerase.

Authors:  Cristina Capella; Michael-John Beltejar; Caitlin Brown; Vincent Fong; Waaqo Daddacha; Baek Kim; Stephen Dewhurst
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

7.  The lipocalin Xlcpl1 expressed in the neural plate of Xenopus laevis embryos is a secreted retinaldehyde binding protein.

Authors:  G Lepperdinger; B Strobl; A Jilek; A Weber; J Thalhamer; H Flöckner; C Mollay
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

8.  Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan.

Authors:  M F Meyer; G Kreil
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding.

Authors:  I Joung; J A Engler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Adenovirus DNA-binding protein forms a multimeric protein complex with double-stranded DNA and enhances binding of nuclear factor I.

Authors:  M H Stuiver; P C van der Vliet
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.